3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Laryngeal Neoplasms
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Advanced Glioblastoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
sugemalimab
1
pegaspargase
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.